Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400085576Phase 4Not yet recruiting
Phase 4, randomised trial in well-being comparing Propofol group with Etomidate group (2 arms). Primary endpoints: Quality of Recovery-15 score and Proportion of patients with blood pressure or heart rate fluctuation greater than ±20% from baseline. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400085576.